Assessment of the substrate for atrial fibrillation using tissue velocity imaging of the fibrillating wall

Assessment of the substrate for atrial fibrillation using tissue velocity imaging of the fibrillating wall - Assessment of the substrate for AF using TVI of the fibrillating wall

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON36728

Enrollment

229

Registered

2011-05-11

Start date

2011-05-12

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with acute paroxysmal AF referred for pharmacological cardioversion or patients with persistent AF referred for electrical cardioversion.

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

Measure	Time frame
Primary endpoint: persistent AF during one year follow-up.	—

Secondary

Measure	Time frame
(a) conversion to sinus rhythm (b) serial AFCL-TVI and AFV-TVI assessments completed (c) development of persistent AF on amiodarone (d) development of persistent AF or major adverse cardiovascular or cerebrovascular events during 3-5 years follow-up.	—

Countries

Netherlands

Outcome results